Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)
15.97
+0.31 (1.98%)
Apr 30, 2025, 3:04 PM CST
SHE:000623 Revenue
Jilin Aodong Pharmaceutical Group had revenue of 622.62M CNY in the quarter ending March 31, 2025, a decrease of -27.71%. This brings the company's revenue in the last twelve months to 2.37B, down -32.67% year-over-year. In the year 2024, Jilin Aodong Pharmaceutical Group had annual revenue of 2.61B, down -24.31%.
Revenue (ttm)
2.37B
Revenue Growth
-32.67%
P/S Ratio
7.89
Revenue / Employee
412.86K
Employees
5,745
Market Cap
18.72B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.61B | -838.55M | -24.31% |
Dec 31, 2023 | 3.45B | 580.91M | 20.25% |
Jan 1, 2023 | 2.87B | 564.45M | 24.50% |
Jan 1, 2022 | 2.30B | 52.11M | 2.31% |
Dec 31, 2020 | 2.25B | -836.73M | -27.09% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |